Piper Sandler analyst Jason Bednar maintained a Hold rating on Masimo (MASI – Research Report) today and set a price target of $117.00. The company’s shares closed last Friday at $132.21.
According to TipRanks, Bednar is an analyst with an average return of -3.8% and a 42.20% success rate. Bednar covers the Healthcare sector, focusing on stocks such as Align Tech, Cooper Co, and Envista Holdings.
Masimo has an analyst consensus of Moderate Buy, with a price target consensus of $128.33.
See the top stocks recommended by analysts >>
The company has a one-year high of $198.00 and a one-year low of $75.22. Currently, Masimo has an average volume of 705.1K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Masimo (MASI) Company Description:
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
Read More on MASI:
- MASI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Masimo Corp Announces Board Reshuffle and Director Resignation
- Masimo announces FDA-cleared ‘over-the-counter’ fingertip pulse oximeter
- What Wall Street experts are saying about Apple ahead of earnings
- Masimo price target raised to $145 from $125 at BTIG
